Bone Abstracts

Abstract unavailable....

Anabolic drug (AD) options are currently limited to PTH analogs. With potent bone-forming effects, AD offer marked increases in BMD. However, the demonstration of their efficacy on fracture risk reduction was possibly limited by the early discontinuation of the pivotal trial for safety concerns. Therefore, their use must rely both in the available evidence as well as in the clinical judgment for the individual patient. Indeed, potential contraindications are the first step in ...